Related Experiment Video
Updated: Jul 27, 2025

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Downregulation of fibrosis related hsa-miR-29c-3p in human CAKUT
Natasa Macak1, Ivan Jovanovic1, Maja Zivkovic1
1Laboratory for Radiobiology and Molecular Genetics, Vinča Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Abstract:
Congenital anomalies of the kidney and urinary tract (CAKUT) represent structural and functional urinary system malformations and take place as one of the most common congenital malformations with an incidence of 1:500. Ureteral obstruction-induced hydronephrosis is associated with renal fibrosis and chronic kidney diseases in the pediatric CAKUT. We aimed to construct interaction network of previously bioinformatically associated miRNAs with CAKUT differentially expressed genes in order to prioritize those associated with fibrotic process and to experimentally validate the expression of selected miRNAs in CAKUT patients compared to control group. We constructed interaction network of hsa-miR-101-3p, hsa-miR-101-5p and hsa-miR-29c-3p that showed significant association with fibrosis. The top enriched molecular pathway was extracellular matrix-receptor interaction (adjusted p = .0000263). We experimentally confirmed expression of three miRNAs (hsa-miR-29c-3p, hsa-miR-101-3p and hsa-miR-101-5p) in obstructed ureters (ureteropelvic junction obstruction and primary obstructive megaureter) and vesicoureteral reflux. The hsa-miR-29c-3p was shown to have lower expression in both patient groups compared to controls. Relative levels of hsa-miR-101-5p and hsa-miR-101-3p showed significant positive correlations in both groups of patients. Statistically significant correlation was observed between hsa-miR-101 (-3p and -5p) and hsa-miR-29c-3p only in the obstructed group. The significant downregulation of anti-fibrotic hsa-miR-29c-3p in obstructive CAKUT could explain activation of genes involved in fibrotic processes. As miRNAs are promising candidates in therapeutic approaches our results need further measurement of fibrotic markers or assessment of extent of fibrosis and functional evaluation of hsa-miR-29c.
Insights
Congenital anomalies of the kidney and urinary tract (CAKUT) are common. Lower expression of anti-fibrotic hsa-miR-29c-3p in obstructive CAKUT may drive fibrosis, suggesting therapeutic potential for miRNAs.
Area of Science:
- Pediatric Nephrology
- Molecular Biology
- Genetics
Background:
- Congenital anomalies of the kidney and urinary tract (CAKUT) are frequent, with ureteral obstruction leading to hydronephrosis, renal fibrosis, and chronic kidney disease in children.
- MicroRNAs (miRNAs) are implicated in CAKUT pathogenesis, particularly in fibrotic processes.
Purpose of the Study:
- To construct a miRNA-gene interaction network for CAKUT to identify fibrosis-associated miRNAs.
- To experimentally validate the expression of selected miRNAs in pediatric CAKUT patients with obstructive conditions.
Main Methods:
- Bioinformatic analysis to build a miRNA-gene interaction network.
- Prioritization of miRNAs associated with fibrotic processes.
- Quantitative real-time PCR to measure miRNA expression in patient samples (obstructed ureters, vesicoureteral reflux) and controls.
Main Results:
- Identified hsa-miR-101-3p, hsa-miR-101-5p, and hsa-miR-29c-3p as significantly associated with fibrosis.
- Extracellular matrix-receptor interaction was the top enriched molecular pathway.
- Experimentally confirmed expression of these three miRNAs in CAKUT patients.
- Observed significantly lower expression of hsa-miR-29c-3p in obstructed CAKUT groups compared to controls.
- Found positive correlations between hsa-miR-101-5p/hsa-miR-101-3p levels and a significant correlation between hsa-miR-101 (-3p/-5p) and hsa-miR-29c-3p in the obstructed group.
Conclusions:
- The significant downregulation of anti-fibrotic hsa-miR-29c-3p in obstructive CAKUT may contribute to the activation of fibrotic genes.
- miRNAs, particularly hsa-miR-29c-3p, represent promising candidates for therapeutic interventions in CAKUT-related fibrosis.
- Further studies are needed to measure fibrotic markers, assess fibrosis extent, and evaluate the functional role of hsa-miR-29c.

